Page last updated: 2024-10-27

fluorouracil and Neuroectodermal Tumors

fluorouracil has been researched along with Neuroectodermal Tumors in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Neuroectodermal Tumors: Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milano, MT1
Chmura, SJ1
Garofalo, MC1
Rash, C1
Roeske, JC1
Connell, PP1
Kwon, OH1
Jani, AB1
Heimann, R1
Ijiri, R1
Onuma, K1
Ikeda, M1
Kato, K1
Toyoda, Y1
Nagashima, Y1
Ito, Y1
Abiko, Y1
Tanaka, Y1

Trials

1 trial available for fluorouracil and Neuroectodermal Tumors

ArticleYear
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
    International journal of radiation oncology, biology, physics, 2004, Jun-01, Volume: 59, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplasti

2004

Other Studies

1 other study available for fluorouracil and Neuroectodermal Tumors

ArticleYear
Pigmented intraosseous odontogenic carcinoma of the maxilla: a pediatric case report and differential diagnosis.
    Human pathology, 2001, Volume: 32, Issue:8

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Ch

2001